Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhythmic versus continuous transdermal estradiol for bone turnover in postmenopausal women
NL-OMON53396Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol and progesterone in osteoporosis (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Interaction between treatment and time on serum P1NP. Started Jul 2023; status: completed.
02
Drugs
estradiolprogesterone
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NL-OMON53396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53396.